Astellas Pharma Inc. Registered Shares o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

38.42%

Market Cap

20.78 Bil.

P/E Ratio

15.48

Dividend Yield

3.10 %

Earnings per Share

0.93 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE11.7 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 10:33:06 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW11.811.6
PREV. DAY'S PRICE11.6 (07/20)
CHANGE DAY BEFORE
+0.10
0.86 %
52 WEEK HIGH / LOW14.475 (04/01)8.152 (07/22)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.060.170.931.000.97
DIVIDENDS PER SHARE
0.450.450.450.430.44
DIVIDEND YIELD IN %
4.26 %5.12 %3.10 %--
DIVIDEND GROWTH IN %
4.79 %1.19 %-1.24 %--
PRICE - EARNINGS RATIO
172.9151.0315.4811.6111.94
PRICE - BOOK RATIO
1.851.712.47--
PRICE - SALES RATIO
1.841.362.12--
PRICE - CASH FLOW RATIO
16.3112.897.99--
Further Key Figures

Master Data

WKN
856273
ISIN
JP3942400007
SYMBOL
YPH
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Astellas Pharma
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Japanese Yen
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
1.79 Bil.
MARKET CAPITALISATION
20.78 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-0.86 %
0.00 %
-17.27 %
-5.15 %
38.42 %
-9.73 %
-20.99 %
1.86 %
HIGH11.5012.1013.8014.4814.4814.4816.1014.48
LOW11.1011.1011.1011.108.157.787.7811.10

Dividende

pro Aktie

Company profile

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.